Free Access
Issue |
Med Sci (Paris)
Volume 29, Number 10, Octobre 2013
|
|
---|---|---|
Page(s) | 834 - 836 | |
Section | Nouvelles | |
DOI | https://doi.org/10.1051/medsci/20132910007 | |
Published online | 18 October 2013 |
Med Sci (Paris) 2013 ; 29 : 834–836
Première caractérisation d’un inhibiteur allostérique des récepteurs des fibroblast growth factors
SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling
Unité de recherche et développement E2C (Early to candidate department), Sanofi R&D, 195, route d’Espagne, 31036 Toulouse Cedex, France
Cet article ne possède pas de résumé.
© 2013 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
First page of the article